Literature DB >> 15660526

Inherited susceptibility to colorectal cancer.

Peter T Rowley1.   

Abstract

The principal Mendelian disorders predisposing to colorectal cancer are familial adenomatous polyposis (FAP) and hereditary nonpolyposis colorectal cancer (HNPCC). FAP is due to mutations in the APC gene. HNPCC is due to a mutation in one of at least five mismatch repair genes. Identification of individuals with these conditions is important because colon cancer will occur in approximately 80% and onset is early. For FAP, protein truncation testing will identify the vast majority of mutations. For HNPCC, 80%-95% can be identified by microsatellite instability testing. A current U.S. study reports that 12% of consecutive colorectal cancers have high microsatellite instability and that, of this 12%, 25% have detectable mutations of MLH1, MSH2, or MSH6. Potential benefits of identification include improved compliance with recommended surveillance, early detection of polyps, reduction in cancer mortality, offering of testing to relatives, and reassurance for relatives found to be negative with attendant savings in the time and expense of surveillance.

Entities:  

Mesh:

Year:  2005        PMID: 15660526     DOI: 10.1146/annurev.med.56.061704.135235

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


  22 in total

1.  Natural products and colon cancer: current status and future prospects.

Authors:  Subapriya Rajamanickam; Rajesh Agarwal
Journal:  Drug Dev Res       Date:  2008-11-01       Impact factor: 4.360

Review 2.  Genetic architecture of colorectal cancer.

Authors:  Ulrike Peters; Stephanie Bien; Niha Zubair
Journal:  Gut       Date:  2015-07-17       Impact factor: 23.059

3.  Association between the hMSH2 IVS12-6 T>C polymorphism and cancer risk: A meta-analysis.

Authors:  Song Wu; Jingyu Chen; Yong Ji; Yuxin Liu; Lu Gao; Guoqiang Chen; Kai Shen; Bin Huang
Journal:  Exp Ther Med       Date:  2011-08-16       Impact factor: 2.447

Review 4.  Models of carcinogenesis: an overview.

Authors:  Paolo Vineis; Arthur Schatzkin; John D Potter
Journal:  Carcinogenesis       Date:  2010-04-29       Impact factor: 4.944

5.  The phenotypic expression of three MSH2 mutations in large Newfoundland families with Lynch syndrome.

Authors:  Susan Stuckless; Patrick S Parfrey; Michael O Woods; Janet Cox; G William Fitzgerald; Jane S Green; Roger C Green
Journal:  Fam Cancer       Date:  2007       Impact factor: 2.375

6.  Interaction of proliferating cell nuclear antigen with PMS2 is required for MutLα activation and function in mismatch repair.

Authors:  Jochen Genschel; Lyudmila Y Kadyrova; Ravi R Iyer; Basanta K Dahal; Farid A Kadyrov; Paul Modrich
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-24       Impact factor: 11.205

Review 7.  Epidemiology and management options for colorectal cancer in children.

Authors:  Raya Saab; Wayne L Furman
Journal:  Paediatr Drugs       Date:  2008       Impact factor: 3.022

Review 8.  Recurrent gene fusions in prostate cancer.

Authors:  Chandan Kumar-Sinha; Scott A Tomlins; Arul M Chinnaiyan
Journal:  Nat Rev Cancer       Date:  2008-06-19       Impact factor: 60.716

Review 9.  Mechanisms in E. coli and Human Mismatch Repair (Nobel Lecture).

Authors:  Paul Modrich
Journal:  Angew Chem Int Ed Engl       Date:  2016-05-20       Impact factor: 15.336

10.  Distinct structural alterations in proliferating cell nuclear antigen block DNA mismatch repair.

Authors:  Lynne M Dieckman; Elizabeth M Boehm; Manju M Hingorani; M Todd Washington
Journal:  Biochemistry       Date:  2013-08-02       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.